secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2022-12-28T23:59:59+00:00
Accession:  0001558370-22-019017
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences completes 1-for-50 reverse stock split, authorized shares increased to 300M
--------------------------------------------------------------------------------

- Reverse stock split effective at trading open on December 23, 2022; each 50 shares become 1 share.
- Authorized common shares increased from 100M to 300M; no reduction in preferred or common authorized.
- Fractional shares rounded up to nearest whole share; proportional adjustments to warrants, options, preferred.
- Stockholders approved the reverse split and authorized share increase at annual meeting on December 14, 2022.
- Series D Mirroring Preferred Stock automatically terminated effective with the reverse split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000155837022019017/0001558370-22-019017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000155837022019017/rsls-20221221x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-019017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer